|
Centre for Policy on Ageing | |
 | |
|
The treatment of stupor associated with MRI evidence of cerebrovascular disease | Author(s) | Jon Spear, Maya Ranger, Joe Herzberg |
Journal title | International Journal of Geriatric Psychiatry, vol 12, no 8, August 1997 |
Pages | pp 791-794 |
Keywords | Depression ; Cerebrovascular diseases ; Drugs ; Psychiatric treatment ; Case studies ; London. |
Annotation | The treatment and outcome of organic stupor associated with MRI (magnetic resonance imaging) evidence of cerebrovascular disease is described with reference to a case series of three patients at a mental health service for older people in south-east London. The patients were aged 69, 72 and 78; two had organic catatonic disorder, and the third, organic depressive disorder. Treatments used were diazepam, carbamazepine, antidepressants or electroconvulsive therapy (ECT). Symptoms resolved between 1 and 10 days. All patients were able to return home, but relapsed over the following 12 months. One relapse occurred when a patient stopped diazepam and moclobemide. It is proposed that the initial treatment of organic stupor associated with cerebrovascular disease should include a benzodiazepine or carbamazepine. If patients fail to respond, then ECT should be considered. The safety of ECT is not known, when treating patients with depressive disorder associated with cerebrovascular disease. (RH). |
Accession Number | CPA-980827250 A |
Classmark | ENR: CQ5: LLD: LP: 69P: 82L |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|